The store will not work correctly when cookies are disabled.
rac-2-(6-Methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
ID: ALA4080780
PubChem CID: 130471695
Max Phase: Preclinical
Molecular Formula: C22H17N3O4
Molecular Weight: 387.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(cc1N1C(=O)c3cccc4cccc(c34)C1=O)n(C)c(=O)n2C
Standard InChI: InChI=1S/C22H17N3O4/c1-23-15-10-17(18(29-3)11-16(15)24(2)22(23)28)25-20(26)13-8-4-6-12-7-5-9-14(19(12)13)21(25)27/h4-11H,1-3H3
Standard InChI Key: DWEBZJMPQVJZAL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
25.0523 -9.3339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4786 -9.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7616 -8.9225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0511 -10.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3366 -10.5777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3374 -11.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0585 -11.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7634 -10.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7635 -11.3972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4697 -11.8025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1802 -11.3971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1801 -10.5779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4695 -10.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8923 -11.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8899 -12.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6046 -13.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6053 -11.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3207 -11.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3253 -12.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1165 -12.8923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5984 -12.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1090 -11.5474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8966 -10.1633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4685 -12.6287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3587 -10.7600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3748 -13.6769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4246 -12.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1728 -13.0494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1710 -13.8757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
15 28 1 0
28 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 387.40 | Molecular Weight (Monoisotopic): 387.1219 | AlogP: 2.84 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.54 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.67 | CX LogD: 2.67 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.50 | Np Likeness Score: -0.75 |
References
1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630] [10.1021/acs.jmedchem.7b00306] |